Skip to main content
. 2021 Feb;22(2):633–640. doi: 10.31557/APJCP.2021.22.2.633

Table 3.

Immunomarking for the Opioids Mu (µ), Kappa (k) and VEGF in Biopsies of Patients with Breast CA with Molecular Subtype Luminal A and Luminal B

Markers Luminal A Luminal B p-Value
µ opioid (%)
Primary tumor 3.30±4.40 3.29±3.36 0.897
Peritumoral area 0.83±1.60 1.30±2.67 1
Lymph node metastasis 3.86±3.58 4.33±3.51 0.836
κ opioid (histoescore)
Primary tumor 10.67±2.65 11.08±1.75 0.987
Peritumoral area 9.50±5.00 11.42±1.38 0.721
Lymph node metastasis 9.83±2.56 10.40±2.87 0.796
VEGF (histoescore)
Primary tumor 8.78±3.60 7.24±3.73 0.348
Peritumoral area 4.80±4.55 4.44±3.92 0.971
Lymph node metastasis 8.29±3.55 8.74±3.45 0.83

Mann-Whitney test; p<0.05 (mean ±SD)